For the Dec-20 quarter, the consolidated operating profits were up 39.32% at Rs623.03cr. The company has deployed cost optimization and inventory efficiency measures to improve profitability. The sharp growth in operating profits is in spite of a sharp spike in raw material expenses and additional incentives worth Rs.34 crore paid to employees for COVID work appreciation. OPM expanded from 32.03% in Dec-19 quarter to 36.62% in Dec-20 quarter.
The consolidated Profit after tax (PAT) for the Dec-20 quarter was up 31.06% at Rs470.62cr as the operational trickle-down effect helped the bottom line too. PAT margins improved from 25.72% in the Dec-19 quarter to 27.66% in the Dec-20 quarter.
Financial highlights for Dec-20 compared yoy and sequentially
|
Divi’s Laboratories |
|||||
|
Rs in Crore |
Dec-20 |
Dec-19 |
YOY |
Sep-20 |
QOQ |
|
Total Income (Rs cr) |
₹ 1,701.44 |
₹ 1,396.26 |
21.86% |
₹ 1,749.30 |
-2.74% |
|
Operating Profit (Rs cr) |
₹ 623.03 |
₹ 447.20 |
39.32% |
₹ 680.01 |
-8.38% |
|
Net Profit (Rs cr) |
₹ 470.62 |
₹ 359.09 |
31.06% |
₹ 519.59 |
-9.42% |
|
Diluted EPS (Rs) |
₹ 17.73 |
₹ 13.53 |
₹ 19.57 |
||
|
OPM |
36.62% |
32.03% |
38.87% |
||
|
Net Margins |
27.66% |
25.72% |
29.70% |
||
Related Tags:
Recent Comments